PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer
| Image |  |
|---|---|
| Description | scientific article published on 21 December 2020 |
| Author/s |
author: Pierre Laurent-Puig |
| Publication date | December 21, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |